Stryker Corp.
Ronda E Stryker (Director) sells SYK shares
AI-generated summary
Director Ronda E Stryker sold 550,000 shares of common stock indirectly through a revocable trust on November 6, 2026, for a total value of $178,924,730.94 at an average price of $325.32 per share. Following these transactions, the holding decreased to 1,701,375 shares held indirectly.
Key facts
- Insider
- Ronda E Stryker · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | S · open-market saleFootnotes F1 | −33,466 | $323.19 | $10,815,843.07 | 2,217,909 | Indirect (By Revocable Trust) |
| Nov 6, 2026 | S · open-market saleFootnotes F2 | −131,707 | $324.09 | $42,685,053.34 | 2,086,202 | Indirect (By Revocable Trust) |
| Nov 6, 2026 | S · open-market saleFootnotes F3 | −142,794 | $325.11 | $46,423,614.55 | 1,943,408 | Indirect (By Revocable Trust) |
| Nov 6, 2026 | S · open-market saleFootnotes F4 | −149,357 | $325.97 | $48,685,453.22 | 1,794,051 | Indirect (By Revocable Trust) |
| Nov 6, 2026 | S · open-market saleFootnotes F5 | −82,089 | $327.03 | $26,845,565.67 | 1,711,962 | Indirect (By Revocable Trust) |
| Nov 6, 2026 | S · open-market saleFootnotes F6 | −10,587 | $327.69 | $3,469,201.10 | 1,701,375 | Indirect (By Revocable Trust) |
Footnotes
- F1 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $322.56 to $323.555, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F2 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $323.56 to $324.555, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F3 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $324.56 to $325.558, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F4 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $325.56 to $326.555, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F5 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $326.56 to $327.555, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- F6 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $327.56 to $328.01, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
More SYK filings
- 8-K
Filed Nov 9, 2026
- 144
Filed Nov 5, 2026
- S-3ASR
Filed Nov 4, 2026
- IRANNOTICE
Filed Oct 30, 2026
- 10-Q
Filed Oct 30, 2026
- 8-K
Filed Oct 29, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.